2015
DOI: 10.1016/j.pep.2014.11.013
|View full text |Cite
|
Sign up to set email alerts
|

Expression and immunoaffinity purification of recombinant soluble human GPR56 protein for the analysis of GPR56 receptor shedding by ELISA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 42 publications
0
9
0
Order By: Relevance
“…Agonistic antibodies directed to GPR56 have been reported but their mechanisms of action are not fully understood (Ohta et al, 2015, Yang et al, 2015). The lack of well-characterized agonists and antagonists has hampered mechanistic studies of GPR56 and other aGPCRs.…”
Section: Discussionmentioning
confidence: 99%
“…Agonistic antibodies directed to GPR56 have been reported but their mechanisms of action are not fully understood (Ohta et al, 2015, Yang et al, 2015). The lack of well-characterized agonists and antagonists has hampered mechanistic studies of GPR56 and other aGPCRs.…”
Section: Discussionmentioning
confidence: 99%
“…The powerful combination of ECR-targeted synthetic proteins, including monobodies and antibodies (35,40,51), with 7TM-targeted small molecule ligands will be invaluable in future mechanistic and pharmacological studies of aGPCRs.…”
Section: Discussionmentioning
confidence: 99%
“…Shedding is likely to generate distinct soluble receptor fragments that have different cellular functions from the membrane-bound proteins. Previously, we and others have detected the presence of soluble GPR56 (sGPR56; the NTF that has been shed from the membrane) in transfected cells, suggesting constitutive GPR56 shedding (Chiang et al, 2011;Jin et al, 2007;Yang et al, 2015). More intriguingly, expression of a truncated GPR56 receptor that lacked the NTF was shown to signal constitutively (Paavola et al, 2011).…”
Section: Introductionmentioning
confidence: 91%
“…DNA and protein reagents were obtained from Invitrogen (Carlsbad, CA), Qiagen (Valencia, CA) and Amersham (GE Healthcare). The CG-2 and CG-3 monoclonal antibodies (mAb) against GPR56 have been described previously (5 µg/ml) (Yang et al, 2015). FITC-conjugated goat anti-mouse IgG was from Jackson ImmunoResearch (West Grove, PA).…”
Section: General Reagents and Cell Culturementioning
confidence: 99%
See 1 more Smart Citation